Age-related and Gender Aspects of Inflammatory Bowel Diseases in the Republic of Dagestan
https://doi.org/10.22416/1382-4376-2022-32-4-68-74
Abstract
Aim: Creation of a patient registry in the Republic of Dagestan to study various aspects of the course and outcomes of IBD, depending on the age and gender of patients.
Materials and methods. We have created a register of IBD patients in the Republic of Dagestan. It included 168 IBD patients aged 17 to 70 years, 69 males and 99 females, the average age of patients with IBD was 38.1 ± 2.5 years with an average duration of illness of 6.19 ± 0.71 years. The diagnosis of IBD was established on the basis of the characteristic clinical picture of the disease, objective status, results of laboratory, endoscopic, X-ray and morphological research in accordance with Russian Clinical Guidelines
Results. The prevalence of IBD in the Republic of Dagestan is 5.41 cases per 100,000 population. The progression of IBD is more often observed in women, aged 30 to 39 years, residents of rural areas. Anemia (mainly chronic iron deficiency) was registered in 66.1 %, more often in women, its maximum frequency was noted in patients aged 20–29 years (80 %). Disability due to IBD was registered in 55.4 % of patients.
Conclusions. The creation of a register of IBD patients in the Republic of Dagestan is aimed at monitoring the state of health, timely monitoring of the effectiveness of therapy and improving the quality of medical care.
About the Authors
S. Sh. AkhmedkhanovRussian Federation
Seipula Sh. Akhmedkhanov – Dr. Sci. (Med.), Professor, Head of the Department of Internal Diseases of Pediatric and Dental Faculties
367000, Republic of Dagestan, Makhachkala, Lenin sq., 1
G. H. Abakarova
Russian Federation
Gulbariyat H. Abakarova — Cand. Sci. (Med.), Assistant of the Department of Propaedeutics of Internal Diseases
367000, Republic of Dagestan, Makhachkala, Lenin sq., 1
A. T. Beibalayeva
Russian Federation
Albina T. Beibalayeva — Assistant of the Department of Internal Diseases of Pediatric and Dental Faculties
367000, Republic of Dagestan, Makhachkala, Lenin sq., 1
B. S. Abdullayeva
Russian Federation
Bariyat S. Abdullayeva — Assistant of the Department of Internal Diseases of Pediatric and Dental Faculties
367000, Republic of Dagestan, Makhachkala, Lenin sq., 1
Z. M. Saidova
Russian Federation
Zaira M. Saidova — Assistant of the Department of Internal Diseases of Pediatric and Dental Faculties
367000, Republic of Dagestan, Makhachkala, Lenin sq., 1
References
1. Ivashkin V.T., Shelygin Yu.A., Belousova E.A., Abdulganieva D.I., Alexeeva O.A., Achkasov S.I., et al. Crohn`s disease. Clinical recommendations (preliminary version). Koloproktologia. 2020;19(2):8–38 (In Russ.). DOI: 10.33878/2073-7556-2020-19-2-8-38
2. Ivashkin V.T., Shelygin Yu.A., Belousova E.A., Abdulganieva D.I., Alexeeva O.A., Achkasov S.I., et al. Project: clinical guidelines for the diagnostics and treatment of ulcerative colitis. Koloproktologia. 2019;18(4):7–36 (In Russ.). DOI: 10.33878/2073-7556-2019-18-4-7-36
3. Khalif I., Shapina M. Inflammatory bowel disease treatment in Eastern Europe: current status, challenges and needs. Current Opinion in Gastroenterology. 2017;33(4):230–3. DOI: 10.1097/MOG.0000000000000370
4. Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769–78. DOI: 10.1016/S0140-6736(17)32448-0
5. Kaplan G.G., Ng S.C. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1(4):307–16. DOI: 10.1016/S2468-1253(16)30077-2
6. Benchimol E.I., Bernstein C.N., Bitton A., Murthy S.K., Nguyen G.C., Lee K., et al. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada. J Can Assoc Gastroenterol. 2019;2(Suppl 1):S1–S5. DOI: 10.1093/jcag/gwy052
7. Kaplan G.G., Bernstein C.N., Coward S., Bitton A., Murthy S.K., Nguyen G.C., et al. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology. J Can Assoc Gastroenterol. 2019;2(Suppl 1):S6–S16. DOI: 10.1093/jcag/gwy054
8. Peery A.F., Crockett S.D., Murphy C.C., Lund J.L., Dellon E.S., Williams J.L., et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156(1):254–72.e11. DOI: 10.1053/j.gastro.2018.08.063
9. Betteridge J.D., Armbruster S.P., Maydonovitch C., Veerappan G.R. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis. 2013;19(7):1421–7. DOI: 10.1097/MIB0b013e318281334d
10. Belousova E.A., Abdulganieva D.I., Alexeeva O.P., Alexeenko S.A., Baranovsky A.Yu., Valuyskikh E.Yu., et al. Social and demographic characteristics, Features of dis- ease course and treatment options of inflammatory bower disease in Russia: results of two multicenter studies. Almanac of Clinical Medicine. 2018;46(5):445–63 (In Russ.). DOI: 10.18786/2072-0505-2018-46-5-445-463
11. Le Blanc J-F., Wiseman D.l., Lakatos P.L., Bessissow T. Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape. World J Gastroenterol. 2019;25(30):4158–71. DOI: 10.3748/wjg.v25.i30.4158
12. Wilson A., Reyes E., Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: A systematic review of the literature. Am. J. Med. 2004;116:44S–9S. DOI: 10.1016/j.amjmed.2003.12.011
13. Filmann N., Rey J., Schneeweiss S., Ardizzone S., Bager P., Bergamaschi G., et al. Prevalence of anemia in inflammatory bowel diseases in European countries: A systematic review and individual patient data meta-analysis. Inflamm. Bowel Dis. 2014;20:936–45.
14. Akhmedkhanov S.Sh. Iron-deficiency anemia of young age. Dis... Dr. med. sci. Makhachkala; 2000 (In Russ.).
15. Baranovskyi A.Yu., Kondrashina E.A, Segal A.M. New system of special gastroenterological care providing in St. Petersburg. Terarchiv, 2013;85(2):17–20 (In Russ).
16. Bezhadezhnykh T.P., Fedyaev D.V., Khachtryan G.R., Arutynov G.G., Gerasimova K.V. Economic evaluation of medical care providing for patients with inflammatory bowel disease on the example of Tatarstan republic. Pharmacoeconomy. Sovremennaya pharmacoeconomica I pharmacoepidemiologia. 2019;12(1):14–26 (In Russ).
Review
For citations:
Akhmedkhanov S.Sh., Abakarova G.H., Beibalayeva A.T., Abdullayeva B.S., Saidova Z.M. Age-related and Gender Aspects of Inflammatory Bowel Diseases in the Republic of Dagestan. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):68-74. https://doi.org/10.22416/1382-4376-2022-32-4-68-74